Prevalence of HBV and HCV markers among patients attending the Saint Camille Medical Centre in Ouagadougou

Pakistan Journal of Biological Sciences

Volumn 15, Issue 10, 2012, Pages 484-489

  Zeba, M T A ^a,b   Ouattara, C A T ^c   Karou, S D ^a,b   Bisseye, C ^a,b   Ouermi, D ^a,b   Djigma, F W ^a,b   Sagna, T ^a,b   Pietra, V ^a,b   Moret, R ^a,b   Nikiema, J ^a,b   Simpore, J ^a,b  

^a Centre de Recherche Biomoléculaire Pietro Annigoni CERBA   (Burkina Faso)

^b CERBA/LABIOGENE ^*  (Burkina Faso)

^c UNIVERSITÉ DE OUAGADOUGOU   (Burkina Faso)

Author keywords

Burkina Faso; Infection; Public health; Viral hepatitis

Indexed keywords

EID: 84867531298     PISSN: 10288880     EISSN: 18125735     Source Type: Journal    
DOI: 10.3923/pjbs.2012.484.48     Document Type: Article

References (39)

1. Agbenu, E., A. Banla, M. Kolou, A. D'Almeida, A. Kpotsra, A. Dorkenoo and D. Redah, 2008. Serologic markers used for hepatitis B surveillance in Togo: Status report and action proposals. Med. Trop., 68: 621-624.
2. Balan, A., N. Beldescu and R. Popa, 1998. The prevalence of viral hepatitis B in pregnant women in an area of southern Romania. Bacteriol. Virusol. Parazitol. Epidemiol., 43: 254-260.
3. Bosan, A., H. Qureshi, K.M. Bile, I. Ahmad and R. Hafiz, 2010. A review of hepatitis viral infections in Pakistan. J. Pak. Med. Assoc., 60: 1045-1058.
4. Buseri, F., E. Seiyaboh and Z. Jeremiah, 2010. Surveying infections among pregnant women in the Niger Delta, Nigeria. J. Global Infectious Dis., 2: 203-211.
5. CDC, 2008. Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. Morbidity Mortality Weekly Rep., 57: 1-20.
6. Chakraborty, J.B., F. Oakley and M.J. Walsh, 2012. Mechanisms and biomarkers of apoptosis in liver disease and fibrosis. Int. J. Hepatol. (In Press). 10.1155/2012/648915
7. El-Magrahe, H., A.R. Furarah, K. El-Figih, S. El-Urshfany and K.S. Ghenghesh, 2010. Maternal and neonatal seroprevalence of hepatitis B surface antigen (HBsAg) in Tripoli Libiya. J. Infect. Dis. Dev. Ctries., 4: 168-170.
8. Galula, G., C. Buffet, L. Robba and M. Poissonnet, 2006. Assessment of prescription practices for serological tests for viral hepatitis B and C in the Greater Parisian area in 2002. Gastroenterol. Clin. Biol., 30: 517-524.
9. Hoffmann, C.J. and C.L. Thio, 2007. Clinical implications of HIV and hepatitis B co-infection in Asia and Africa. Lancet Infect Dis., 7: 402-409.
10. Hou, J., Z. Wang, J. Cheng, Y. Lin and G.K. Lau et al., 2001. Prevalence of naturally occurring surface gene variants of hepatitis B virus in nonimmunized surface antigen-negative Chinese carriers. Hepatology, 34: 1027-1034.
11. Hwai, I.Y., S. Lu, Y.F. Liaw, S.L. You and C.A. Sun et al., 2002. Hepatitis B e antigen and the risk of hepatocellular carcinoma. N. Engl. J. Med., 347: 168-174.
12. Ilboudo, D., A. Sawadogo and J. Simpore, 2003. Hepatitis C and HIV co-infection in pregnant women, Ouagadougou (Burkina Faso). Med. Maladies Infectieuses, 33: 276-279.
13. Ilboudo, D., D. Karou, W.M.C. Nadembega, A. Savadogo and O.D.S. Pignatelli et al., 2007. Prevalence of human herpes virus-8 and hepatitis B virus among HIV seropositive pregnant women enrolled in the mother-to-child HIV transmission prevention program at saint Camille medical centre in Burkina Faso. Pak. J. Biol. Sci., 10: 2831-2837.
14. Ilboudo, D., J. Simpore, D. Ouermi, C. Bisseye and T. Sagna et al., 2010. Towards the complete eradication of mother-to-child HIV/HBV coinfection at Saint Camille Medical Centre in Burkina Faso, Africa. Braz. J. Infect. Dis., 14: 219-224.
15. Kao, J.H. and D.S. Chen, 2002. Global control of hepatitis B virus infection. Lancet, 2: 395-403.
16. Kazmi, K., A. Ghafoor and A.W. Qureshi, 2003. Mother-infant transmission of hepatitis B in Pakistan. Pak. J. Med. Res., 42: 152-156.
17. Liu, J. and D. Fan, 2007. Hepatitis B in China. Lancet, 369: 1582-1583.
18. Liu, Z. and J. Hou, 2006. Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Dual Infection. Int. J. Med. Sci., 3: 57-62.
19. Lukhwareni, A., R.J. Burnett, S.G. Selabe, M.O. Mzileni and M.J. Mphahlele, 2009. Increased detection of HBV DNA in HBsAg-positive and HBsAg-negative South African HIV/AIDS patients enrolling for highly active antiretroviral therapy at a Tertiary Hospital. J. Med. Virol., 81: 406-412.
20. Michielsen, P.P., S.M. Francque and J.L. van Dongen, 2005. Viral hepatitis and hepatocellular carcinoma. World J. Surg. Oncol., 3: 1-18.
21. Muhammad, N., A. Qasim, G. Jafferi, M. Anwar and M. Muazzam, 2011. HIV infection, HIV/HCV and HIV/HBV co-infections among jail inmates of Lahore. Pak. J. Med. Sci., 27: 837-841.
22. Nagalo, M.B., M. Sanou, C. Bisseye, M.I. Kabore and Y.K. Nebie et al., 2011. Seroprevalence of human immunodeficiency virus, hepatitis B and C viruses and syphilis among blood donors in Koudougou (Burkina Faso) in 2009. Blood Transfus, 9: 419-424.
23. Nagu, T.J., M. Bakari and M. Matee, 2008. Hepatitis A, B and C viral co-infections among HIV-infected adults presenting for care and treatment at Muhimbili National Hospital in Dar es Salaam, Tanzania. BMC Public Health, Vol. 8. 10.1186/1471-2458-8-416
24. Onakewhor, J.U.E., E. Offor and F.E. Okonofua, 2001. Maternal and neonatal seroprevalence of Hepatitis B surface antigen (HBsAg) in Benin City, Nigeria. J. Obstetrics Gynaecol., 21: 583-586.
25. Otegbayo, J.A., B.O. Taiwo, T.S. Akingbola, G.N. Odaibo and K.S. Adedapo et al., 2008. Prevalence of hepatitis B and C seroposotivity in a Nigerian cohort of HIV-infected patients. Ann. Hepatol., 7: 152-156.
26. Ouermi, D., J. Simpore, A.M.G. Belem, D.S. Sanou and D.S. Karou et al., 2009. Co-infection of Toxoplasma gondii with HBV in HIV-infected and uninfected pregnant women in Burkina Faso. Pak. J. Biol. Sci., 12: 1188-1193.
27. Paola, S., E. Girardi, M. Fusco, P. Piselli and S. Russo et al., 2009. Lack of implementation of Hepatitis B Virus (HBV) vaccination policy in household contacts of HBV carriers in Italy. BMC Infect. Dis., Vol. 9. 10.1186/1471-2334-9-86
28. Parkin, D.M., F. Sitas, M. Chirenje, L. Stein, R. Abratt and H. Wabinga, 2008. Part I: Cancer in Indigenous Africans-burden, distribution and trends. Lancet Oncol., 9: 683-692.
29. Pietra, V., D. Kiema, D. Sorgho, S.P.C.G. Kabore and S. Mande et al., 2008. Prevalence of hepatitis B virus markers and hepatitis C virus antibodies in health personnel in the District of Nanoro, Burkina Faso. Sci. Technol., 31: 53-59.
30. Sangare, L., R. Sombie, A.W. Combassere, A. Kouanda, D. Kania, O. Zerbo and J. Lankoande, 2009. Antenatal transmission of hepatitis B virus in an area of HIV moderate prevalence, Burkina Faso. Bull. Soc. Pathol. Exot., 102: 226-229.
31. Schenkel, K., D. Radun, V. Bremer, N. Bocter and O. Hamouda, 2008. Viral hepatitis in Germany: Poor vaccination coverage and little knowledge about transmission in target groups. BMC Public Health, Vol., 8. 10.1186/1471-2458-8-132
32. Simpore, J., A. Savadogo, D. Ilboudo, M.C. Nadembega and M. Esposito et al., 2006. Toxoplasma gondii, HCV and HBV seroprevalence and co-infection among HIV-positive and-negative pregnant women in Burkina Faso. J. Med. Virol., 78: 730-733.
33. Simpore, J., D. Ilboudo, A. Samandoulgou, P. Guardo, P. Castronovo and S. Musumeci, 2004. HCV and HIV co-infection in pregnant women attending St. Camille medical centre in Ouagadougou (Burkina Faso). J. Med. Virol., 75: 209-212.
34. Simpore, J., E. Compaore, J. Sawadogo, F. Djigma and D. Ouermi et al., 2011. Human immunodeficiency virus prevention among HIV-serodiscordant couples in Burkina Faso: Biomedical issues, bioethical and cultural challenges. World J. AIDS, 1: 185-191.
35. Tsay, P.K., D.I. Tai, Y.M. Chen, C.P. Yu, S.Y. Wan, Y.J. Shen and D.Y. Lin, 2009. Impact of gender, viral transmission and aging in the prevalence of hepatitis B surface antigen. Chang Gung Med. J., 32: 155-164.
36. WHO, 2004. Estimated total deaths by cause and WHO member state, 2002. Department of Measurement and Health Information, WHO, Geneva, Switzerland.
37. Wiseman, E., M.A. Fraser, S. Holden, A. Glass and B.L. Kidson et al., 2009. Perinatal transmission of hepatitis B virus: An Australian experience. Med. J. Aust., 190: 489-492.
38. Zanetti, A.R., P. van Damme and D. Shouval, 2008. The global impact of vaccination against hepatitis B: A historical overview. Vaccine, 26: 6266-6273.
39. Zeba, M.T.A., S.D. Karou, T. Sagna, F. Djigma and C. Bisseye et al., 2011. HCV prevalence and co-infection with HIV among pregnant women in Saint Camille Medical Centre, Ouagadougou. Trop. Med. Int. Health, 16: 1392-1396.